Albert Bourla - 28 Apr 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chairman & CEO, Director
Issuer symbol: PFE
Report date: 28 Apr 2023
Net transaction value: +$537
Form type: 4
Accepted by SEC: 01 May 2023, 13:29:54 UTC
Previous filing: 17 Apr 2023
Next filing: 16 May 2023
SEC filing: View on sec.gov
Reporting owner signature: Susan E. Grant, by power of atty., for Albert Bourla

Key filing fact

Albert Bourla filed Form 4 for PFIZER INC (PFE) on 01 May 2023.

Key facts

This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 May 2023, 13:29.

Change

Previous filing in this sequence was filed on 17 Apr 2023.
Current net transaction value: +$537.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Phantom Stock Units SSP

Award

Transaction value: $537
Shares: +14
Change %: +0.01%
Price: $38.39
Shares after: 176,711
Date: 28 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each unit represents one phantom share of common stock.

Footnote F2

These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.